Atopic dermatitis treatment method
OwnerDavid A. Paslininventor
Life of this patent
Estimating the term…
Abstract
Compositions are provided for treating atopic dermatitis, other atopic diseases and other inflammatory or allergic skin disorders. The compositions include proteins from Molluscum Contagiosum Virus (MCV), or fragments, variants, analogs, and derivatives thereof which exhibit AD inhibiting activity. Examples of MCV proteins which exhibit AD inhibiting activity include MC148P1, MC148P2, MC148P3, other MC148P type proteins, and fragments, variants, analogs, and derivatives of MC148P1, MC148P2, MC148P3, and other MC148P type proteins which possess AD inhibiting activity. The fragments, variants, analogs and derivatives may be less than 100% homologous to MCV proteins so long as they are sufficiently homologous such that AD inhibiting activity is preserved.
Claims20
A method for treating a patient having atopic dermatitis, comprising:
- administering to a patient having atopic dermatitis a therapeutically effective amount of a composition comprising a Molluscum Contagiosum viral protein (MC148P) which possesses atopic dermatitis inhibiting activity.
A kit for treating an inflammatory skin disease, comprising:
- multiple separately packaged portions of a composition adapted for treating atopic dermatitis comprising a Molluscum Contagiosum Viral protein (MC148P) which possesses atopic dermatitis inhibiting activity.
Dependencies are inferred from the claim text.